Email me when King Michael files a new Ownership 3,4,5 report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SABS, SABSW | SAB Biotherapeutics, Inc. | Chief Financial Officer | $4.4K | Feb 21, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|